The Discounted Cash Flow (DCF) valuation of Laboratorios Farmaceuticos ROVI SA (ROVI.MC) is 46.58 EUR. With the latest stock price at 55.65 EUR, the upside of Laboratorios Farmaceuticos ROVI SA based on DCF is -16.3%.
Based on the latest price of 55.65 EUR and our DCF valuation, Laboratorios Farmaceuticos ROVI SA (ROVI.MC) is a sell. selling ROVI.MC stocks now will result in a potential gain of 16.3%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 9.6% | 8.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 33.16 - 81.32 | 46.58 |
| Upside | -40.4% - 46.1% | -16.3% |